Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00816231 · ClinicalTrials.gov registry record · NA
Drug /Cue Interactions In Alcohol-Tobacco Comorbidity
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 244
- Enrollment target
NCT00816231 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 244 participants.
The verdict
NCT00816231, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 244 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how people react to different combinations of alcohol and nicotine.
Interventions
- OTHER Placebo
- BEHAVIORAL Tobacco
- OTHER Alcoholic Beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2006-05-08 |
| Est. Completion | 2019-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00816231
The ClinicalTrials.gov registry entry for NCT00816231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00816231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00816231 about?
NCT00816231 is a clinical study titled "Drug /Cue Interactions In Alcohol-Tobacco Comorbidity". The purpose of this study is to determine how people react to different combinations of alcohol and nicotine.
What is the current status of trial NCT00816231?
This trial is currently completed. It is a NA study. The enrollment target is 244 participants. The study started on 2006-05-08. Estimated completion is 2019-06-20.
What interventions are being tested in trial NCT00816231?
The interventions under investigation include: Placebo (OTHER), Tobacco (BEHAVIORAL), Alcoholic Beverage (OTHER).
Who is sponsoring clinical trial NCT00816231?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.